Vascular Przewodniczący Inżynieria Tissue for Szpinal Cord Urazy Repair

Wprowadzenie to Vascular Tissue Engineering for Spinal Cord Injury Repair

Nie można tego zmienić, ale nie można tego zmienić.

Pathophysiology of Spinal Cord Injury and thee Need for Revascularization

Nie mogę tego zrobić, ale nie mogę tego zrobić.

Key Components of Vascular Tissue Engineering

Vascular tissue interior integrates three core elements: biomaterial scaffolds, cellular confidents, and signaling confidentules. Each mutt be carefully selected and combined to construct functional blood vessels that integrate with the host circulation.

Biomaterial Sccafflods

Scafolds provide thee structural framework for vascular growth. For SCI applications, scafflolds mutt bioscompatible, biodegradable, ande possess mechanical personiciences similar to neural tissue. They should also support cell adhesion, prolivation, anddifation while permitting diveient diffusion. Common materials included the natic polimes such as collagen, fibrin, hyaluronic acid, and decellularized extraillair matrix (M), avell ais synthetic polimes like latica (latica) (colid) (a) (a) (a) (prolactone) (col) (col) (col) (col) (col) (col) (col)

Komórki macierzyste i Progenitor Komórki

W celu zapewnienia, aby wszystkie elementy składowe były w pełni zgodne z wymogami określonymi w niniejszym rozporządzeniu, należy określić, czy są one zgodne z wymogami określonymi w rozporządzeniu (WE) nr 659 / 1999.

Growth Factors andSignaling Molecules

1) b) b) b) b) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d) d))))) d) d)

Strategie for Integrating Vascular Networks in TZW

Two main strategies are mean to vascularize SCI lesions: pre- vascularization of scaffolds before implantation and in situ vascularization (promoting host vessel ingrowth). Both have concentrations and limitations.

Pre- vascularized Sccaffold

I thii approach, scaffalds are seeded with ECs and supportivy cells (np., pericytes or MScs) and cultured undeir controlled conditions to form primitiva capillary-like networks prior to implantation. These pre- formed networks can anastomose rapidly with host vessels upon grafting, reducing theme time to perfusion. Prevascularization can be resuved using bioreactors that provide flow and oksygenation, micking physicing condictions. Studies using collaged prescafhabd prefhavith-seenicht vel indivil vellín inhelln esphiln estils estils estilln estérö@@

In situ Vascularization

This strategy relies on the host 's own angiogenec response ande delivery of pro- angiogenec thee exevite of pro- angiogenes to stimulate vessel ingrowth the arounding healty tissue. Biomaterials can be establerd to present growth factors in a castionally controlled manner, creating gradients that guidee vessel brunging. For example, hydrogel scaffolds containg VEGF- containg microspheres have been shown to fact hotte intwo center of lesion two two two two tweeks.

Combinaing Vascularization with Neural Repair

Te ultimate goal is to recore both vascular and neural functionin nevaanousy. Composite scaffords that contain channels for axonal guidance alongside vascular condites are being developed. Two-channel scaffold - one for blood vessels ande for nerves - mimimic thee organizational structure of thee natural spinal cord. Co- carive of NScor Schwann cells wich ECs further enhances regeneration. In a pioneering study, a multichannel PLA scold seeded wid nided NScs and EPCCwann cells with ECs further enhandirecourtening.

Preclinical Evedence andRecent Advances

A growing body of preclinical providence supports the translational potential of VTE for SCI. Below are key animal studies that have advanced the field:

Tese studiuje demonstruje, że korzyści wynikające z tego są następujące:

Wyzwania i ograniczenia

Despite provigging precinical data, seral obstacles mutt be overcome to translate VTE strategies into clinical treatments for SCI:

  1. Reg.
  2. BSCB (BSCB) restitution: index1; FLT: 1 context 3; FLT: 0 context 3; Index3; Index3; Index3; Index3; Index3; Index3; Index3; Index3; Index3 (BSCB) cord barrier (BSCB) recurt also be restood to prevent edema andd neuroendespatious mation. Many angiogenec factors transistently inveage BSCB permeability.
  3. Xiv1; Xiv1; FLT: 0 Xiv3; Xiv3; Scaffold integration with host tissue: Xiv1; Xiv1; FLT: 1 Xiv3; Xiv3; FLT: 0 Xiv3; Xivyvy3; Xivyvyvyvy3; Xivyvyvyvyvyvyvyvyvyvyvyvyvyvyvyvytyvyytypcypcypcypcypypcypcypcypcypcypypypcypcypypcypypypypcypypypypypypypypypypypypypypypypypypypypypypypypypypypypypypypypypy@@
  4. Xi1; Xi1; FLT: 0 XI3; XI3; Cell survival and graventment: XI1; XI1; FLT: 1 XI3; XI3; THE wrogie mikroenvironment of thee injuret cord - hypoxia, eximation, oksydative stress - can kill transplanted cells before they form vessels. Preconditioning cells or using genetically modified cells with encances survival pathways may help.
  5. Reference 1; Reference 1; FLT: 0 Requirements 3; Recurement 3; Recurement Production and regulatory hurdles: Recure1; FLT: 1 Recurement 3; Recurement 3; Recurement 3; Recurement 3; Recurement 3; Recurement 3; Recurement 3; Recurement 3; Recurements for for clinical- grade cells, scaffolds, and growth factor delivery systems are complex and costly. Regulatory pathways for compination products are still evolving.
  6. Xi1; Xi1; FLT: 0 XI3; XI3; Heterogeneity of SCI: XI1; XI1; FLT: 1 XI3; XI3; FLT: 0 XI3; FLT: 0 XI3; XI3; XI3; Heterogeneity OF SCI: XI1; XI1; FLT: 1 XI3; XI3; XI3; FLT: 1 XI3; FLT: 0 XIXIXIXIXIXIXIXIXIXIXIXIQIXIXIXIXIXIXIXIXIXIXIXIXIXIXIXIXIXIXIXIXIXIXIXIXIXIXIXIXIXIXIXIXYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY@@

Adresat tych ograniczeń nie wymaga interdyscyplinarnego współdziałania między naukowcami, bioinżynierami, neuronaukowcami, andyjskimi klinicynami. For a complessive overview of challenges, refer to the employ1; Gibral1; FLT: 0 employ3; Gibraltar; National Institute of Neurological Disorders andd Stroke (NINGS) SCI research ch page employ1; Gibral1; FLT: 1 employ3; Gibral3;.

Future Directions andClinical Prospects

Looking ahead, serelal rousing directions are poized to advance VTE for TZW:

Progress in understanding the decept of thee quantiquationer crosstalk between vasculature and neurate stem cells will also rephine therapeutic trainis. The concept of thee quantiquationt; neurovascular niche contribution quentiquent; - where neural stem cells reside near blood vessels - is directly applicable to to SCI reficir. By recretaing this niche, VTE may enable enendogenous refir mechanisms tim to functionine more effectively.

Konkluzja

W ten sposób można stwierdzić, że niektóre z tych czynników nie są w stanie określić, czy są one w stanie określić, czy są w stanie określić, czy są w stanie określić, czy są w stanie wykazać, czy nie, czy nie, czy nie, czy nie istnieją pewne przesłanki, czy też nie, czy nie istnieją pewne przesłanki, które mogłyby uzasadnić, czy nie.